Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAC-101 in Advanced Hepatocellular Carcinoma
NCT00077142Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2001
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TAC-101 in hepatocellular carcinoma (HCC), sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2001; status: completed.
02
Drugs
TAC-101
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00077142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077142.